View in EDS HTML Full Text PDF Full Text

BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.

Saved in:
Bibliographic Details
Title: BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
Authors: Dupuis-Girod S; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, 59 Bd Pinel, Bron 69677, France.; Laboratory Biology of Cancer and Infection, University Grenoble Alpes, Inserm, CEA, Grenoble, France., Decullier E; Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; Faculté de médecine, Université Lyon 1, Lyon, France., Rivière S; Service de Médecine Interne A, Centre Hospitalier Universitaire, Montpellier, France., Lavigne C; Service de médecine interne-Immunologie clinique, CHU d'Angers, Angers Cedex 09, France., Grobost V; Service de Médecine Interne CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Leguy-Seguin V; Service de Médecine Interne 1, CHU Francois Mitterrand, Dijon, France., Maillard H; Service de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France., Chinet T; Centre Rendu-Osler, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Université de Versailles SQY, Boulogne, France., Fargeton AE; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Centre de Référence de la maladie de Rendu-Osler, Bron, France., Guilhem A; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, Bron, France., Hermann R; Hospices Civils de Lyon, Hôpital, Service d'ORL, Hôpital E. Herriot, Lyon, France.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2025 Apr 14; Vol. 16, pp. 20406207241300828. Date of Electronic Publication: 2025 Apr 14 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40290758
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dupuis-Girod+S%22">Dupuis-Girod S</searchLink>; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, 59 Bd Pinel, Bron 69677, France.; Laboratory Biology of Cancer and Infection, University Grenoble Alpes, Inserm, CEA, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Decullier+E%22">Decullier E</searchLink>; Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; Faculté de médecine, Université Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Rivière+S%22">Rivière S</searchLink>; Service de Médecine Interne A, Centre Hospitalier Universitaire, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Lavigne+C%22">Lavigne C</searchLink>; Service de médecine interne-Immunologie clinique, CHU d'Angers, Angers Cedex 09, France.<br /><searchLink fieldCode="AU" term="%22Grobost+V%22">Grobost V</searchLink>; Service de Médecine Interne CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Leguy-Seguin+V%22">Leguy-Seguin V</searchLink>; Service de Médecine Interne 1, CHU Francois Mitterrand, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Maillard+H%22">Maillard H</searchLink>; Service de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Chinet+T%22">Chinet T</searchLink>; Centre Rendu-Osler, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Université de Versailles SQY, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Fargeton+AE%22">Fargeton AE</searchLink>; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Centre de Référence de la maladie de Rendu-Osler, Bron, France.<br /><searchLink fieldCode="AU" term="%22Guilhem+A%22">Guilhem A</searchLink>; Hospices Civils de Lyon, Hôpital Femme-Mère-Enfants, Service de Génétique et centre de Référence de la maladie de Rendu-Osler, Bron, France.<br /><searchLink fieldCode="AU" term="%22Hermann+R%22">Hermann R</searchLink>; Hospices Civils de Lyon, Hôpital, Service d'ORL, Hôpital E. Herriot, Lyon, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2025 Apr 14; Vol. 16, pp. 20406207241300828. <i>Date of Electronic Publication: </i>2025 Apr 14 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40290758
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/20406207241300828
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20406207241300828
    Titles:
      – TitleFull: BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dupuis-Girod S
      – PersonEntity:
          Name:
            NameFull: Decullier E
      – PersonEntity:
          Name:
            NameFull: Rivière S
      – PersonEntity:
          Name:
            NameFull: Lavigne C
      – PersonEntity:
          Name:
            NameFull: Grobost V
      – PersonEntity:
          Name:
            NameFull: Leguy-Seguin V
      – PersonEntity:
          Name:
            NameFull: Maillard H
      – PersonEntity:
          Name:
            NameFull: Chinet T
      – PersonEntity:
          Name:
            NameFull: Fargeton AE
      – PersonEntity:
          Name:
            NameFull: Guilhem A
      – PersonEntity:
          Name:
            NameFull: Hermann R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 04
              Text: 2025 Apr 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2040-6207
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Therapeutic advances in hematology
              Type: main
ResultId 1